Whitegate Investment Counselors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,522
Closed -$6.49M 68
2021
Q3
$6.49M Buy
30,522
+232
+0.8% +$53.4K 0.92% 31
2021
Q2
$7.38M Sell
30,290
-4,391
-13% -$1.08M 1.05% 27
2021
Q1
$8.63M Buy
34,681
+7
+0% +$1.67K 1.32% 23
2020
Q4
$7.97M Sell
34,674
-573
-2% -$132K 1.29% 23
2020
Q3
$8.96M Sell
35,247
-184
-0.5% -$45.6K 1.63% 17
2020
Q2
$8.36M Sell
35,431
-168
-0.5% -$38.3K 1.67% 16
2020
Q1
$7.22M Sell
35,599
-1,038
-3% -$227K 1.75% 14
2019
Q4
$8.83M Sell
36,637
-531
-1% -$117K 1.6% 16
2019
Q3
$7.19M Sell
37,168
-636
-2% -$122K 1.41% 18
2019
Q2
$6.97M Sell
37,804
-38
-0.1% -$6.8K 1.4% 18
2019
Q1
$7.19M Sell
37,842
-51
-0.1% -$9.74K 1.49% 16
2018
Q4
$7.38M Sell
37,893
-18
-0% -$3.51K 1.71% 12
2018
Q3
$7.86M Sell
37,911
-874
-2% -$172K 1.6% 14
2018
Q2
$7.16M Buy
38,785
+217
+0.6% +$38.4K 1.46% 18
2018
Q1
$6.58M Sell
38,568
-104
-0.3% -$19.1K 1.4% 21
2017
Q4
$6.72M Sell
38,672
-15
-0% -$2.65K 1.4% 20
2017
Q3
$7.21M Sell
38,687
-575
-1% -$102K 1.59% 13
2017
Q2
$6.76M Sell
39,262
-85
-0.2% -$13.8K 1.53% 16
2017
Q1
$6.46M Sell
39,347
-988
-2% -$164K 1.55% 15
2016
Q4
$5.9M Buy
40,335
+805
+2% +$121K 1.58% 17
2016
Q3
$6.59M Sell
39,530
-400
-1% -$67.6K 1.79% 12
2016
Q2
$6.08M Buy
+39,930
New +$6.21M 1.69% 15
2014
Q1
$5.53M Buy
+36,900
New +$4.48M 1.52% 18

Other funds holding AMGN

Whitegate Investment Counselors's AMGN Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Amgen (AMGN) in Q4 2021, closing a stake of 30,522 shares — an estimated $6.49M sold.

Whitegate Investment Counselors first reported a position in AMGN in Q1 2014 and held it in 23 quarters. The position peaked at $8.96M in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 30,522 Amgen shares in Q4 2021, an estimated $6.49M.
  • Whitegate Investment Counselors first reported a position in Amgen in Q1 2014 and held it in 23 quarters.
  • Whitegate Investment Counselors's Amgen position peaked at $8.96M in Q3 2020.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.